Obesity and non-insulin dependent diabetes mellitus. 22-23 April 1998, The Royal Society, London, UK.
This two-day meeting provided researchers with an overview of the broad range of targets for possible drug development by highlighting a range of receptor molecules and factors controlling food intake. The direct or indirect role various proteins play in the development of non-insulin dependent diabetes mellitus (NIDDM) or obesity were discussed. Mutations resulting in NIDDM or obesity in animal models were highlighted, although these mapped mutations have not as yet been shown to be the main cause of NIDDM in humans. This further highlights the complexity of these diseases resulting in a broad spectrum phenotype. The importance of NIDDM and obesity research was stressed in the global forecast contributing to social and economic problems in both developed and developing countries. The management and early detection of NIDDM was proposed as the best means of reducing therapeutic costs and the severity of the diseases.
O'Hanlon
K
K
Current Drugs Limited, Middlesex House, 34-42 Cleveland Street, London, W1P 6LB, UK. karenoh@cursci.co.uk